BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peghin M, Los-Arcos I, Hirsch HH, Codina G, Monforte V, Bravo C, Berastegui C, Jauregui A, Romero L, Cabral E, Ferrer R, Sacanell J, Román A, Len O, Gavaldà J. Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction. Clin Infect Dis 2019;69:1192-7. [PMID: 30561555 DOI: 10.1093/cid/ciy1047] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Morlacchi LC, Rossetti V, Gigli L, Amati F, Rosso L, Aliberti S, Nosotti M, Blasi F. COVID‐19 in lung transplant recipients: A case series from Milan, Italy. Transpl Infect Dis 2020;22. [DOI: 10.1111/tid.13356] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
2 Sweet SC. Community-Acquired Respiratory Viruses Post-Lung Transplant. Semin Respir Crit Care Med 2021;42:449-59. [PMID: 34030206 DOI: 10.1055/s-0041-1729172] [Reference Citation Analysis]
3 Bazemore K, Rohly M, Permpalung N, Yu K, Timofte I, Brown AW, Orens J, Iacono A, Nathan SD, Avery RK, Valantine H, Agbor-Enoh S, Shah PD. Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury. J Heart Lung Transplant 2021:S1053-2498(21)02326-3. [PMID: 34344623 DOI: 10.1016/j.healun.2021.05.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Filippidis P, Vionnet J, Manuel O, Mombelli M. Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review. Expert Rev Anti Infect Ther 2021;:1-18. [PMID: 34854329 DOI: 10.1080/14787210.2022.2013808] [Reference Citation Analysis]
5 Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, Bontempo G, Marrella F, Tommasini A, Fabris M, Curcio F, Isola M, Tascini C. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect 2021:S1198-743X(21)00281-0. [PMID: 34111579 DOI: 10.1016/j.cmi.2021.05.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ison MG, Hirsch HH. Community-Acquired Respiratory Viruses in Transplant Patients: Diversity, Impact, Unmet Clinical Needs. Clin Microbiol Rev 2019;32:e00042-19. [PMID: 31511250 DOI: 10.1128/CMR.00042-19] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 13.7] [Reference Citation Analysis]
7 Ammerman E, Sweet SC, Storch GA, Buller RS, Mason S, Conrad C, Hayes D Jr, Faro A, Goldfarb SB, Melicoff E, Schecter M, Visner G, Heeger PS, Mohanakumar T, Williams N, Danziger-Isakov L. Epidemiology and persistence of rhinovirus in pediatric lung transplantation. Transpl Infect Dis 2020;22:e13422. [PMID: 32686323 DOI: 10.1111/tid.13422] [Reference Citation Analysis]
8 Ju CR, Lian QY, Zhang JH, Qiu T, Cai ZT, Jiang WY, Zhang J, Cheng Q, Chen G, Li N, Wang CY, He JX. Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients. Chronic Dis Transl Med 2020;6:87-97. [PMID: 32363045 DOI: 10.1016/j.cdtm.2020.02.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
9 Trachuk P, Bartash R, Abbasi M, Keene A. Infectious Complications in Lung Transplant Recipients. Lung 2020;198:879-87. [PMID: 33169174 DOI: 10.1007/s00408-020-00403-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Greer M, Werlein C, Jonigk D. Surveillance for acute cellular rejection after lung transplantation. Ann Transl Med 2020;8:410. [PMID: 32355854 DOI: 10.21037/atm.2020.02.127] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 McGinniss JE, Whiteside SA, Simon-Soro A, Diamond JM, Christie JD, Bushman FD, Collman RG. The lung microbiome in lung transplantation. J Heart Lung Transplant 2021;40:733-44. [PMID: 34120840 DOI: 10.1016/j.healun.2021.04.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 van der Ploeg EA, Melgert BN, Burgess JK, Gan CT. The potential of biomarkers of fibrosis in chronic lung allograft dysfunction. Transplant Rev (Orlando) 2021;35:100626. [PMID: 33992914 DOI: 10.1016/j.trre.2021.100626] [Reference Citation Analysis]
13 Timsit JF, Sonneville R, Kalil AC, Bassetti M, Ferrer R, Jaber S, Lanternier F, Luyt CE, Machado F, Mikulska M, Papazian L, Pène F, Poulakou G, Viscoli C, Wolff M, Zafrani L, Van Delden C. Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients. Intensive Care Med 2019;45:573-91. [PMID: 30911807 DOI: 10.1007/s00134-019-05597-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
14 Leuzinger K, Stolz D, Gosert R, Naegele K, Prince SS, Tamm M, Hirsch HH. Comparing cytomegalovirus diagnostics by cell culture and quantitative nucleic acid testing in broncho-alveolar lavage fluids. J Med Virol 2021;93:3804-12. [PMID: 33136288 DOI: 10.1002/jmv.26649] [Reference Citation Analysis]
15 Messika J, Darmon M, Mal H, Pickkers P, Soares M, Canet E, Rello J, Bauer PR, van de Louw A, Lemiale V, Taccone FS, Loeches IM, Schellongowski P, Mehta S, Antonelli M, Kouatchet A, Barratt-Due A, Valkonen M, Bruneel F, Pène F, Metaxa V, Moreau AS, Burghi G, Montini L, Barbier F, Nielsen LB, Mokart D, Chevret S, Zafrani L, Azoulay E; EFRAIM Investigators and the Nine-I Study Group. Etiologies and Outcomes of Acute Respiratory Failure in Solid Organ Transplant Recipients: Insight Into the EFRAIM Multicenter Cohort. Transplant Proc 2020;52:2980-7. [PMID: 32499142 DOI: 10.1016/j.transproceed.2020.02.170] [Reference Citation Analysis]
16 Bitterman R, Kumar D. Respiratory Viruses in Solid Organ Transplant Recipients. Viruses 2021;13:2146. [PMID: 34834953 DOI: 10.3390/v13112146] [Reference Citation Analysis]
17 Mombelli M, Lang BM, Neofytos D, Aubert JD, Benden C, Berger C, Boggian K, Egli A, Soccal PM, Kaiser L, Hirzel C, Pascual M, Koller M, Mueller NJ, van Delden C, Hirsch HH, Manuel O; Swiss Transplant Cohort Study. Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study. Am J Transplant 2021;21:1789-800. [PMID: 33131188 DOI: 10.1111/ajt.16383] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
18 Lewis TC, Lesko M, Rudym D, Lonze BE, Mangiola M, Natalini JG, Chan JCY, Chang SH, Angel LF. One-year immunologic outcomes of lung transplantation utilizing hepatitis C-viremic donors. Clin Transplant 2022;:e14749. [PMID: 35689815 DOI: 10.1111/ctr.14749] [Reference Citation Analysis]
19 de Zwart AES, Riezebos-Brilman A, Alffenaar JC, van den Heuvel ER, Gan CT, van der Bij W, Kerstjens HAM, Verschuuren EAM. Evaluation of 10 years of parainfluenza virus, human metapneumovirus, and respiratory syncytial virus infections in lung transplant recipients. Am J Transplant 2020;20:3529-37. [PMID: 32449200 DOI: 10.1111/ajt.16073] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
20 Munting A, Manuel O. Viral infections in lung transplantation. J Thorac Dis 2021;13:6673-94. [PMID: 34992844 DOI: 10.21037/jtd-2021-24] [Reference Citation Analysis]
21 Saez-Giménez B, Berastegui C, Barrecheguren M, Revilla-López E, Los Arcos I, Alonso R, Aguilar M, Mora VM, Otero I, Reig JP, Quezada CA, Pérez V, Valle M, Laporta R, Deu M, Sacanell J, Bravo C, Gavalda J, Lopez-Meseguer M, Monforte V. COVID-19 in lung transplant recipients: A multicenter study. Am J Transplant 2021;21:1816-24. [PMID: 33089648 DOI: 10.1111/ajt.16364] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
22 Mombelli M, Kampouri E, Manuel O. Influenza in solid organ transplant recipients: epidemiology, management, and outcomes. Expert Review of Anti-infective Therapy 2020;18:103-12. [DOI: 10.1080/14787210.2020.1713098] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
23 Kim MY, Brennan DC, Shah P. General Approach to the Clinical Care of Solid Organ Transplant Recipients with COVID-19 Infection: Management for Transplant Recipients. Curr Transplant Rep 2020;:1-13. [PMID: 33145146 DOI: 10.1007/s40472-020-00305-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Ramos KJ, Pilewski JM, Taylor-Cousar JL. Challenges in the use of highly effective modulator treatment for cystic fibrosis. J Cyst Fibros 2021;20:381-7. [PMID: 33531206 DOI: 10.1016/j.jcf.2021.01.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Sweet SC, Chin H, Conrad C, Hayes D Jr, Heeger PS, Faro A, Goldfarb S, Melicoff-Portillo E, Mohanakumar T, Odim J, Schecter M, Storch GA, Visner G, Williams NM, Kesler K, Danziger-Isakov L. Absence of evidence that respiratory viral infections influence pediatric lung transplantation outcomes: Results of the CTOTC-03 study. Am J Transplant 2019;19:3284-98. [PMID: 31216376 DOI: 10.1111/ajt.15505] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
26 Morrell ED, Brager C, Ramos KJ, Chai XY, Kapnadak SG, Edelman J, Matute-Bello G, Altemeier WA, Hwang B, Mulligan MS, Bhatraju PK, Wurfel MM, Mikacenic C, Lease ED, Limaye AP, Fisher CE. CXCL10 and Soluble Programmed Death-Ligand 1 during Respiratory Viral Infections Are Associated with Chronic Lung Allograft Dysfunction in Lung Transplant Recipients. Am J Respir Cell Mol Biol 2022;66:577-9. [PMID: 35486077 DOI: 10.1165/rcmb.2021-0404LE] [Reference Citation Analysis]